文献速递肿瘤 PET/CT甲状腺核医学

小细胞肺癌全身18F-FDG PET/CT再分期中的甲状腺转移

Thyroid Metastasis in Whole-Body 18F-FDG PET/CT Restaging of Small Cell Lung Cancer.
PubMed 文献 · Clin Nucl Med · 2022-01-01

本文报道一例65岁女性小细胞肺癌患者,既往有多发甲状腺结节(分类为良性结节性甲状腺肿)。在18F-FDG PET/CT再分期中,这些甲状腺病灶显示FDG摄取增高且病变进展,遂行细针穿刺,于首次肿瘤诊断后14个月证实为小细胞肺癌甲状腺转移。

要点

  • 肿瘤患者全身FDG PET/CT中甲状腺偶发病灶常见,部分伴FDG摄取增高。
  • 甲状腺转移极罕见,甲状腺病灶是良性甲状腺肿还是需进一步评估常存争议。
  • 本例甲状腺病灶FDG摄取增高且进展,细针穿刺证实为小细胞肺癌转移。

核心结论

  • 甲状腺病灶在FDG PET/CT再分期中显示摄取增高和进展时,经细针穿刺证实为小细胞肺癌转移。

研究设计与样本

  • 本文为病例报告,对象为一名65岁女性小细胞肺癌患者,甲状腺有多发病灶并分类为良性结节性甲状腺肿。

主要发现

  • 再分期18F-FDG PET/CT显示甲状腺病灶FDG摄取增高且病变进展。
  • 细针穿刺结果证实为小细胞肺癌转移,时间为首次肿瘤诊断后14个月。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Incidental findings of thyroid lesions, some of which show increased FDG uptake, are common in whole-body FDG PET/CT imaging of oncological patients. As metastases to the thyroid are extremely rare, it is often a matter of debate, whether thyroid lesions should be considered as benign goiter or evaluated further. Here, we present the case of a 65-year-old woman with history of small cell lung cancer and multiple thyroid lesions, classified as benign nodular goiter. Because in restating using 18F-FDG PET/CT these lesions showed an increased FDG uptake and growth progression, decision was made for fine-needle aspiration, which revealed small cell lung cancer metastasis 14 months after first tumor diagnosis.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Vogel J, Tenev A, Solass W, et al. Thyroid Metastasis in Whole-Body 18F-FDG PET/CT Restaging of Small Cell Lung Cancer. Clin Nucl Med. 2022. PMID: 34874354. doi:10.1097/RLU.0000000000003748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。